Free Trial

Sernova (SVA) Competitors

Sernova logo
C$0.16 0.00 (0.00%)
As of 02:13 PM Eastern

SVA vs. BCT, IPA, TH, ONC, SCYB, COM, NVH, APS, IGX, and COV

Should you be buying Sernova stock or one of its competitors? The main competitors of Sernova include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Theratechnologies (TH), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), Aptose Biosciences (APS), IntelGenx Technologies (IGX), and Covalon Technologies (COV). These companies are all part of the "biotechnology" industry.

Sernova vs. Its Competitors

BriaCell Therapeutics (CVE:BCT) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

BriaCell Therapeutics currently has a consensus price target of C$15.00, indicating a potential upside of 41.51%. Sernova has a consensus price target of C$2.00, indicating a potential upside of 1,150.00%. Given Sernova's stronger consensus rating and higher probable upside, analysts clearly believe Sernova is more favorable than BriaCell Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BriaCell Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Sernova
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Sernova's return on equity of 473.85% beat BriaCell Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BriaCell TherapeuticsN/A N/A N/A
Sernova N/A 473.85%-119.26%

BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19
SernovaN/AN/A-C$35.70M-C$0.10-1.54

In the previous week, BriaCell Therapeutics had 3 more articles in the media than Sernova. MarketBeat recorded 4 mentions for BriaCell Therapeutics and 1 mentions for Sernova. Sernova's average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -0.04 indicating that Sernova is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BriaCell Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sernova
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

0.1% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Sernova beats BriaCell Therapeutics on 10 of the 12 factors compared between the two stocks.

Get Sernova News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVA vs. The Competition

MetricSernovaBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$53.84MC$131.19MC$5.51BC$6.28B
Dividend Yield7.86%3.74%4.25%6.72%
P/E Ratio-1.543.6128.1354.46
Price / SalesN/A4,390.41401.971,124.64
Price / Cash6.1513.1935.5383.29
Price / Book-3.7540.808.264.99
Net Income-C$35.70M-C$92.15MC$3.24BC$301.20M
7 Day PerformanceN/A1.10%0.65%0.79%
1 Month Performance-3.03%5.27%8.13%4.44%
1 Year Performance-45.76%166.48%28.59%25.22%

Sernova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVA
Sernova
1.9199 of 5 stars
C$0.16
flat
C$2.00
+1,150.0%
-46.7%C$53.84MN/A-1.541,959
BCT
BriaCell Therapeutics
N/AC$10.60
-3.8%
C$15.00
+41.5%
+0.0%C$168.68MN/A-28.195
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
TH
Theratechnologies
N/AC$4.33
+0.5%
N/A+99.1%C$138.15MC$52.22M-49.01103
ONC
Oncolytics Biotech
1.6228 of 5 stars
C$1.59
-1.9%
C$3.50
+120.1%
+14.9%C$122.55MN/A-4.4329News Coverage
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%
N/A+0.0%C$102.38MN/A0.00N/AHigh Trading Volume
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/A0.00N/A
NVH
Novoheart
N/AC$0.53
+1.9%
N/A+0.0%C$99.98MC$423.50K-13.95N/A
APS
Aptose Biosciences
N/AC$2.29
+2.2%
N/A-91.9%C$98.60MN/A-0.4631Gap Up
IGX
IntelGenx Technologies
N/AC$0.58
+1.8%
N/A+0.0%C$87.32MC$1.75M-7.442,050Gap Up
COV
Covalon Technologies
N/AC$2.69
-2.2%
N/A+24.3%C$73.70MC$27.87M30.88N/ANews Coverage
Positive News

Related Companies and Tools


This page (TSE:SVA) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners